Sanofi SNYNF
NASDAQ SNYNF
$90.01 +3.08 (+3.54%)
At close: Aug 18, 2026 · 4:00 PM EDT

Sanofi (SNYNF) EBIT (2009 - 2026)

Sanofi (SNYNF) posted EBIT of $16.3 billion for Q2 2026, up 13.96% sequentially from $14.3 billion in Q1 2026, and up 20.28% YoY from $13.5 billion in Q2 2025.

Sanofi (SNYNF) EBIT (2009 - 2026) Analysis & Trends

Sanofi has reported EBIT for 18 years, with the latest figure at $16.3 billion in Q2 2026.

  • Quarterly EBIT rose 20.28% year-over-year to $16.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $86.5 billion (up 35.23% YoY) and the FY2025 annual result came in at $7.4 billion, down 4.71% from the prior year.
  • EBIT climbed to $16.3 billion in Q2 2026 per SNYNF's latest filing, from $14.3 billion in the prior quarter.
  • Over five years, EBIT peaked at $47.8 billion in Q4 2023 and troughed at $11.4 billion in Q1 2024.
  • A 5-year average of $18.9 billion and a median of $13.7 billion in 2022 frame the typical range for EBIT.
  • The sharpest annual moves came in 2024 and 2025: EBIT tumbled 50.96% in 2024, then surged 199.59% in 2025.
  • Over 5 years, EBIT stood at $40.1 billion in 2022, then rose by 19.08% to $47.8 billion in 2023, then sank by 50.96% to $23.4 billion in 2024, then sank by 48.49% to $12.1 billion in 2025, then jumped by 34.57% to $16.3 billion in 2026.
  • According to Business Quant data, EBIT over the past three periods registered $16.3 billion, $14.3 billion, and $12.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 16.25 Bn
Mar 31, 2026 14.26 Bn
Dec 31, 2025 12.08 Bn
Sep 30, 2025 43.92 Bn
Jun 30, 2025 13.51 Bn
Mar 31, 2025 12.36 Bn
Dec 31, 2024 23.44 Bn
Sep 30, 2024 14.66 Bn
Jun 30, 2024 11.87 Bn
Mar 31, 2024 11.45 Bn
Dec 31, 2023 47.80 Bn
Sep 30, 2023 14.26 Bn
Jun 30, 2023 12.65 Bn
Mar 31, 2023 12.83 Bn
Dec 31, 2022 40.14 Bn
Sep 30, 2022 13.80 Bn
Jun 30, 2022 12.51 Bn
Mar 31, 2022 12.39 Bn
Dec 31, 2021 35.33 Bn
Sep 30, 2021 13.33 Bn